Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 10, 2024 and accepted by EDGAR at May 10, 2024, 20:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:Revenues |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:GrossProfit |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $422.4k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $671.5k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | −$1.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$1.0m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | −$896.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 3 months2024-01-01 to 2024-03-31 | $82.8k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2024-03-31 | $9.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $9.6m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $391.0k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $391.0k | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $9.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-24-002695. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.